Literature DB >> 8491227

Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.

S J Wang1, R S Liu, H C Liu, K N Lin, D E Shan, K K Liao, J L Fuh, L S Lee.   

Abstract

Regional cerebral blood flow was assessed in 19 patients with early idiopathic Parkinson's disease (PD) and 12 control subjects of similar age by single-photon emission tomography using technetium-99m hexamethylpropylene amine oxime (HMPAO). Of the patients with PD, seven were mildly demented and 15 presented with hemiparkinsonism. Mean HMPAO cortical or basal ganglia/cerebellum activity ratios were calculated. Mean cortical and regional uptake ratios in non-demented PD patients were not significantly different from values in the controls. In contrast, besides generalized cortical hypoperfusion, demented PD patients had significantly lower HMPAO uptake in the frontal and basal ganglia regions than non-demented patients. These observations support the hypothesis of impaired neuronal activity in both cortical and subcortical regions of the brain in demented PD patients. In hemiparkinsonian patients, the only asymmetrical finding was a relative hypoperfusion in the contralateral parietal region. This may be due to deafferentation of the thalamoparietal pathways. The lack of asymmetrical uptake in basal ganglia in our PD patients may be explained by their staging at the time of the investigation (stage I and II, Hoehn and Yahr scale).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491227     DOI: 10.1007/BF00169811

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  25 in total

1.  [99mTc]-HM-PAO SPECT in Parkinson's disease.

Authors:  G Pizzolato; M Dam; N Borsato; B Saitta; C Da Col; N Perlotto; P Zanco; G Ferlin; L Battistin
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

2.  Regional blood flow in hemiparkinsonism.

Authors:  J S Perlmutter; M E Raichle
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

3.  Cerebral blood flow studied by Xenon-133 inhalation technique in parkinsonism: loss of hyperfrontal pattern.

Authors:  A Bès; A Güell; N Fabre; P Dupui; G Victor; G Géraud
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Cognitive deficits in the early stages of Parkinson's disease.

Authors:  A J Lees; E Smith
Journal:  Brain       Date:  1983-06       Impact factor: 13.501

6.  A subcortico-cortical cholinergic system is affected in Parkinson's disease.

Authors:  B Dubois; M Ruberg; F Javoy-Agid; A Ploska; Y Agid
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

7.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

8.  Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.

Authors:  J L Montastruc; P Celsis; A Agniel; J F Demonet; B Doyon; M Puel; J P Marc-Vergnes; A Rascol
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338

9.  Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.

Authors:  K A Johnson; B L Holman; S P Mueller; T J Rosen; R English; J S Nagel; J H Growdon
Journal:  Arch Neurol       Date:  1988-04

10.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  3 in total

1.  Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients.

Authors:  Kathy Dujardin; Luc Defebvre; Alain Duhamel; Pascal Lecouffe; Pascal Rogelet; Marc Steinling; Alain Destée
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 2.  The significance of neuronal lateralisation in Parkinson's disease.

Authors:  P Riederer; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2012-02-26       Impact factor: 3.575

3.  Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.

Authors:  Y Abe; T Kachi; T Kato; Y Arahata; T Yamada; Y Washimi; K Iwai; K Ito; N Yanagisawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.